(Q35197020)

7 August 2017

1 reference

title

Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma (English)

1 reference

7 August 2017

1 reference

Wolthers OD

1

1 reference

7 August 2017

1 August 2003

1 reference

Pediatric Allergy & Immunology

7 August 2017

1 reference

7 August 2017

14

1 reference

7 August 2017

4

1 reference

7 August 2017

248-254

1 reference

Inflammatory mechanisms in childhood asthma

7 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

The concept of airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Mechanisms of eosinophil-associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

The role of inflammation in airway disease: remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Determinants of eosinophil cationic protein in nasal lavages in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Analysis of sputum taken from wheezy and asthmatic infants and children, with special reference to respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum-processing methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Sampling methods: urine/blood analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Serum eosinophil cationic protein during treatment of asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Circadian variations in serum eosinophil cationic protein, and serum and urine eosinophil protein X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Seasonal differences of peak expiratory flow rate variability and mediators of allergic inflammation in non-atopic adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Urinary eosinophil protein X in children with asthma: influence of atopy and airway infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Asthma severity and inflammation markers in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Markers of inflammation and bronchial reactivity in children with asthma, exposed to animal dander in school dust

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

Ultrastructure of airways in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Inflammatory mediators in bronchoalveolar lavage samples from children with and without asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Epithelial injury by human eosinophils

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Bronchoalveolar lavage and tracheal aspirate for assessing airway inflammation in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Brush biopsy and mucosal biopsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Serum eosinophil cationic protein in the evaluation of asthma severity in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Urinary eosinophil protein X in relation to disease activity in childhood asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Circadian variation of urinary eosinophil protein X in asthmatic and healthy children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Upper airway sampling

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Circadian variation in nasal reactivity in children with allergic rhinitis: correlation with the activity of eosinophils and basophilic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Prospective longitudinal study of urinary eosinophil protein X in children with asthma and chronic cough

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

The eosinophilic leukocyte: structure and function

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Intracellular expression and serum levels of eosinophil peroxidase (EPO) and eosinophil cationic protein in asthmatic children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Effect of a bed covering system in children with asthma and house dust mite hypersensitivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Effect of clotting temperature and eosinophil concentration on the eosinophil cationic protein concentration in serum

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Detection by enzyme-linked immunosorbent assay and purification from normal human urine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Eosinophil and mast cell parameters in children with stable moderate asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Circannual rhythms of plasma luteinizing hormone, follicle-stimulating hormone, testosterone, prolactin and cortisol in prepuberty.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Immunopathology of allergy and asthma in childhood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Is serum eosinophil cationic protein in bronchiolitis a predictor of asthma?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Nasopharyngeal eosinophil cationic protein in bronchiolitis: relation to viral findings and subsequent wheezing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

High levels of eosinophil cationic protein in wheezing infants predict the development of asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Markers of allergy & inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Serum level of eosinophil cationic protein in patients with chronic cough: relationship to blood eosinophils and airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Eosinophil cationic protein in the sera of patients with Mycoplasma pneumonia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Can eosinophil-derived proteins be used to diagnose or to monitor childhood asthma?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Inflammation markers and symptom activity in children with bronchial asthma. Influence of atopy and eczema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

How much asthma is really attributable to atopy?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Dissociation between Airway Inflammation and Airway Hyperresponsiveness in Allergic Asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Clinical value of monitoring eosinophil activity in asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2003.00030.X

7 January 2021

10.1034/J.1399-3038.2003.00030.X

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12911500